ASX:MSBBiotechs
Is Mesoblast (ASX:MSB) Offering Value After Recent Share Price Declines?
Wondering if Mesoblast at around A$2.02 is giving you genuine value or just fresh volatility? This article walks through what the numbers are actually saying about the stock.
The share price has had a mixed run, with a 7 day return of an 11.0% decline and a 30 day return of a 4.3% decline, set against a year to date return of a 27.1% decline, a 1 year return of 25.9%, and a 3 year return of 112.0%.
These moves sit alongside ongoing attention on Mesoblast's position in the biotech sector and...